The DOI matches its Crossref record; 136 of the 153 references it cites were found in a registry or an index.
Congenital adrenal hyperplasia.
Abstract
Congenital adrenal hyperplasia (CAH) due to deficiency of 21-hydroxylase is a disorder of the adrenal cortex characterised by cortisol deficiency, with or without aldosterone deficiency, and androgen excess. Patients with the most severe form also have abnormalities of the adrenal medulla and epinephrine deficiency. The severe classic form occurs in one in 15,000 births worldwide, and the mild non-classic form is a common cause of hyperandrogenism. Neonatal screening for CAH and gene-specific prenatal diagnosis are now possible. Standard hormone replacement fails to achieve normal growth and development for many children with CAH, and adults can experience iatrogenic Cushing's syndrome, hyperandrogenism, infertility, or the development of the metabolic syndrome. This Seminar reviews the epidemiology, genetics, pathophysiology, diagnosis, and management of CAH, and provides an overview of clinical challenges and future therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“21-Hydroxylase deficiency, caused by mutations in P450c21, is the most common form of CAH and one of the most common inborn errors of metabolism.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [409]
In the citing paper
“Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders characterized by a defect in cortisol biosynthesis (1).”
From Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia (2012) · cites this paper as [1]
In the citing paper
“The most frequent cause of primary AI is autosomal recessive congenital adrenal hyperplasia (CAH), which results from defects in enzymes involved in steroid biosynthesis (Merke and Bornstein, 2005).”
From Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells (2018) · cites this paper as Merke and Bornstein, 2005
In the citing paper
“Lifelong glucocorticoid replacement therapy with hydrocortisone is standard of care for CAH patients and personalized replacement therapy through precision medicine is essential in optimizing care ( Merke and Bornstein, 2005 ; Hindmarsh, 2009 ; Kamoun et al., 2013 ).”
From Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach (2023) · cites this paper as Merke and Bornstein, 2005
Citations
Cites
Stress hormones: their interaction and regulation
Axelrod, J., & Reisine, T. D. (1984) · Science · doi:10.1126/science.6143403 · Cited by 1,527
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
A Consensus Statement on Health Care Transitions for Young Adults With Special Health Care Needs
American Academy of Pediatrics, American Academy of Family Physicians, & American College of Physicians-American Society of Internal Medicine (2002) · PEDIATRICS · doi:10.1542/peds.110.s3.1304 · Cited by 894
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Vogeser, M., Zachoval, R., Felbinger, T. W., Jacob, K., Radetti, G., Bona, G., Corrias, A., Cappa, M., DeSanctis, V., Lauriola, S., et al. (2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 452
Hines, M., Brook, C. G. D., & Conway, G. S. (2004) · The Journal of Sex Research · doi:10.1080/00224490409552215 · Cited by 445
Non-compliance and transfer from paediatric to adult transplant unit
Watson, A. R. (2000) · Pediatric Nephrology · doi:10.1007/s004670050794 · Cited by 428
Doupe, A. J., Landis, S. C., & Patterson, P. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-08-02119.1985 · Cited by 399
Research works printed but not linked: 17
- Speiser, 1985, High frequency of nonclassical steroid 21-hydroxylase deficiency, Am J Hum Genet, 37, 650
- Fitness, 1999, Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia, J Clin Endocrinol Metab, 84, 960
- Kawaguchi, 1992, Evolutionary origin of mutations in the primate cytochrome P450c21 gene, Am J Hum Genet, 50, 766
- Tajima, 1993, De novo mutation causes steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblings, J Clin Endocrinol Metab, 77, 86
- Wilson, 1995, Steroid 21 hydroxylase deficiency: genotype may not predict phenotype, J Clin Endocrinol Metab, 80, 2322
- Jaaskelainen, 1997, Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population, J Clin Endocrinol Metab, 82, 3293
- Knochenhauer, 1997, Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism, J Clin Endocrinol Metab, 82, 479
- Speiser, 1992, Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency, J Clin Endocrinol Metab, 75, 1421
- Nordenstrom, 1999, Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21 hydroxylase deficiency, J Clin Endocrinol Metab, 84, 1505
- Azziz, 1994, Clinical review 56: nonclassic adrenal hyperplasia: current concepts, J Clin Endocrinol Metab, 78, 810
- New, 1988, Growth and final height in classical and nonclassical 21-hydroxylase deficiency, Acta Paediatr Jpn, 30, 79
- David, 1994, Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Arch Pediatr, 1, 363
- Jaaskelainen, 2000, Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency, Acta Obstet Gynecol Scand, 79, 687
- Feldman, 1992, Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 74, 635
- Lo, 1999, Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab, 84, 930
- Margolis, 1974, Experimental adenovirus infection of the mouse adrenal gland. I. Light microscopic observations, Am J Pathol, 75, 363
- Stauber, 1978, Experimental intraamnionic exposure of bovine fetuses with subgroup 2, type 7 adenovirus, Can J Comp Med, 42, 466
Cited by
Sorted by citations
Items 101–200 of 628
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch13 · Cited by 51
Bonfig, W., & Schwarz, H. P. (2014) · Clinical Endocrinology · doi:10.1111/cen.12498 · Cited by 49
Growth and development in children with classic congenital adrenal hyperplasia
Bonfig, W. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000308 · Cited by 51
Genetic mechanisms of human hypertension and their implications for blood pressure physiology
Seidel, E., & Scholl, U. I. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00032.2017 · Cited by 52
Wang, R., Yu, Y., Ye, J., Han, L., Qiu, W., Zhang, H., Liang, L., Gong, Z., Wang, L., & Gu, X. (2016) · Steroids · doi:10.1016/j.steroids.2016.01.007 · Cited by 47
Haddad, N. G., & Eugster, E. A. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.04.007 · Cited by 49
Mueller, S. C., Grissom, E. M., & Dohanich, G. P. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.015 · Cited by 51
Bachelot, A., Golmard, J. L., Dulon, J., Dahmoune, N., Leban, M., Bouvattier, C., Cabrol, S., Leger, J., Polak, M., & Touraine, P. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0978 · Cited by 46
Young, W. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00016-x · Cited by 46
Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies
Sarafoglou, K., Barnes, C. N., Huang, M., Imel, E. A., Madu, I.-J., Merke, D. P., Moriarty, D., Nakhle, S., Newfield, R. S., Vogiatzi, M. G., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab438 · Cited by 46
“Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is an autosomal recessive disorder with an estimated incidence of 1:7000 to 1:18 000 live births worldwide (1-3), in which decreased adrenal biosynthesis of cortisol leads to accumulation of cortisol precursors, hyperplasia of the ad…”
BackgroundInfluentialSelf-citationGlucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
Ventura, A., Brunetti, G., Colucci, S. C., Oranger, A., Ladisa, F., Cavallo, L., Grano, M., & Faienza, M. F. (2012) · BioMed Research International · doi:10.1155/2013/250462 · Cited by 45
Daae, E., Feragen, K. B., Nermoen, I., & Falhammar, H. (2018) · Endocrine · doi:10.1007/s12020-018-1723-0 · Cited by 45
Congenital Adrenal Hyperplasia Because of 21-Hydroxylase Deficiency
Trakakis, E., Loghis, C., & Kassanos, D. P. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318193301b · Cited by 43
Hardy, R., & Cooper, M. S. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.06.007 · Cited by 43
Ullmann, E., Barthel, A., Petrowski, K., Tobias Stalder, A., Kirschbaum, C., & Bornstein, S. R. (2016) · Scientific Reports · doi:10.1038/srep25842 · Cited by 44
Self-citationBacila, I. A., Adaway, J., Hawley, J. M., Mahdi, S., Krone, R. E., Patel, L., Alvi, S., Randell, T. L., Gevers, E. F., Dattani, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00031 · Cited by 44
Herting, M. M., Azad, A., Kim, R., Tyszka, J. M., Geffner, M. E., & Kim, M. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa023 · Cited by 41
“CYP21A2 gene, affecting 1 in 15,000 live births, and is the most common cause of primary adrenal insufficiency in children (1).”
BackgroundInfluentialMarkmann, S., De, B. P., Reid, J., Jose, C. L., Rosenberg, J. B., Leopold, P. L., Kaminsky, S. M., Sondhi, D., Pagovich, O., & Crystal, R. G. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.203 · Cited by 42
Disorders of sex development: advances in genetic diagnosis and challenges in management
Ahmed, F., Kyriakou, A., Tobias, E. S., Lucas-Herald, A. K., & McGowan, R. (2015) · Advances in Genomics and Genetics · doi:10.2147/agg.s53226 · Cited by 44
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 45
Krone, N. P., Grischuk, Y., Müller, M., Volk, R. E., Grötzinger, J., Holterhus, P., Sippell, W. G., & Riepe, F. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0209 · Cited by 44
Voice characteristics in women with congenital adrenal hyperplasia due to 21‐hydroxylase deficiency
Nygren, U., Södersten, M., Falhammar, H., Thorén, M. C., Hagenfeldt, K., & Nordenskjöld, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03347.x · Cited by 43
Nermoen, I., Brønstad, I., Fougner, K. J., Svartberg, J. B., Øksnes, M., Husebye, E. S., & Løvås, K. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0196 · Cited by 43
Bramble, M. S., Lipson, A., Vashist, N., & Vilain, E. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23832 · Cited by 42
“…both XX and XY CAH patients are supplemented with lifelong mineralocorticoid and glucocorticoid replacement therapies in the forms of fludrocortisone and hydrocortisone to supplement their cortisol deficiency and reduce the overproduction of hormone precursors (Merke and Bornstein, 2005).”
BackgroundManagement of Childhood Congenital Adrenal Hyperplasia—An Integrative Review of the Literature
Fleming, L., Riper, M. L. V., & Knafl, K. A. (2017) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2017.02.004 · Cited by 41
“If the dosage of hydrocortisone is insufficient, children are Children with CAH are steroid dependent for life. at a high risk for precocious puberty and adrenal crisis (Merke & Bornstein, 2005).”
BackgroundInfluentialNon-Classical Congenital Adrenal Hyperplasia in Childhood
Kurtoğlu, S., & Hatipoğlu, N. (2016) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3378 · Cited by 42
Ezquieta, B., Beneyto, M., Muñoz‐Pacheco, R., Barrio, R., Oyarzabal, M., Lechuga, J. L., Luzuriaga, C., Hermoso, F., González, S. Q., & Martinez, S. (2006) · Prenatal Diagnosis · doi:10.1002/pd.1584 · Cited by 39
“…(21OHD) (the most common form of congenital adrenal hyperplasia (CAH)) is offered to couples whose developing child is at-risk of suffering from the disease (Speiser and White, 2000; Donohue et al., 2001; CAH Working Group, 2002; Lajic et al., 2004; Merke and Bornstein, 2005; Wedell et al., 1994a).”
BackgroundBringing GC–MS profiling of steroids into clinical applications
Choi, M. H., & Chung, B. C. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21436 · Cited by 40
Falhammar, H., Nyström, H. F., & Thorén, M. C. (2014) · Endocrine · doi:10.1007/s12020-013-0161-2 · Cited by 39
Moreira, R. P. P., Gomes, L. G., Mendonca, B. B., & Bachega, T. A. S. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044893 · Cited by 38
Pilar Vigil, P., Ana, C. L. D., Flores, B., Rioseco, H., & Serrano, F. G. (2017) · The Linacre Quarterly · doi:10.1080/00243639.2017.1394053 · Cited by 38
Hampson, E., & ROVET, J. F. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.01.022 · Cited by 38
Silveira, E. L., Santos, Ε. Ρ., Bachega, T. A. S. S., Nader, I., Gross, J. L., & Elnecave, R. H. (2008) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2008.21.5.455 · Cited by 37
Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?
Falhammar, H. (2014) · Endocrine · doi:10.1007/s12020-013-0162-1 · Cited by 37
Adrenal gland and other paraganglia
(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06969-4.00011-8 · Cited by 37
Age-specific changes in sex steroid biosynthesis and sex development
Krone, N., Hanley, N. A., & Arlt, W. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.06.001 · Cited by 36
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 36
Beyond Pink and Blue: The Complexity of Early Androgen Effects on Gender Development
Berenbaum, S. A. (2017) · Child Development Perspectives · doi:10.1111/cdep.12261 · Cited by 39
Trakakis, E., Rizos, D., Loghis, C., Chryssikopoulos, A., Spyropoulou, M., SALAMALEKIS, E., SIMEONIDES, G., VAGOPOULOS, V., Salamalekis, G., & Kassanos, D. P. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07-053 · Cited by 36
Urinary continence outcomes following vaginoplasty in patients with congenital adrenal hyperplasia
Stites, J., Bernabé, K. J., Galan, D., Felsen, D., & Poppas, D. P. (2017) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2016.10.012 · Cited by 35
Gender Identity in Patients with Congenital Adrenal Hyperplasia
Razzaghy‐Azar, M., Karimi, S., & Shirazi, E. (2017) · Intern J Endocrinol Metab · doi:10.5812/ijem.12537 · Cited by 35
Grischuk, Y., Rubtsov, P., Riepe, F. G., Grötzinger, J., Beljelarskaia, S., Prassolov, V., Kalintchenko, N., Semitcheva, T., Peterkova, V., Tiulpakov, A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0777 · Cited by 33
Bachelot, A., Vialon, M., Baptiste, A., Téjédor, I., Elie, C., Polak, M., Touraine, P. A., & _, _. (2017) · Endocrine Connections · doi:10.1530/ec-17-0094 · Cited by 34
Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency
Pussard, E., Travers, S. A. A., Bouvattier, C. M., Xue, Q.-Y., Cosson, C., Viengchareun, S., Martinerie, L., & Lombès, M. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105553 · Cited by 37
Schaeffer, T. L., Tryggestad, J. B., Mallappa, A., Hanna, A., Krishnan, S., Chernausek, S. D., Chalmers, L. J., Reiner, W. G., Kropp, B. P., & Wisniewski, A. B. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/692439 · Cited by 42
Harbeck, B., Kropp, P. A., & Mönig, H. (2009) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-009-9082-5 · Cited by 34
Melin, J., Parra-Guillen, Z. P., Michelet, R., Truong, T., Huisinga, W., Hartung, N., Hindmarsh, P., & Kloft, C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa071 · Cited by 34
Mueller, S. C., Mandell, D., Leschek, E., Pine, D. S., Merke, D. P., & Ernst, M. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.031 · Cited by 33
Self-citationBaş, F., Toksoy, G., Ergun-Longmire, B., Uyguner, Z. O., Abalı, Z. Y., Poyrazoğlu, Ş., Karaman, V., Avcı, Ş., Altunoğlu, U., Bundak, R., et al. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.04.001 · Cited by 35
Adrenocortical hyperplasia: a review of clinical presentation and imaging
Morani, A. C., Jensen, C. T., Habra, M. A., Agrons, M. M., Menias, C. O., Wagner‐Bartak, N. A., Shaaban, A. M., Roman-Colon, A. M., & Elsayes, K. M. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02048-6 · Cited by 32
Chen, W., Kim, M. S., Shanbhag, S. M., Arai, A. E., VanRyzin, C., McDonnell, N. B., & Merke, D. P. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33092 · Cited by 31
“Carriership for CYP21A2 mutations is estimated to be as high as 10% globally, with varying frequencies in different populations [Merke and Bornstein, 2005].”
BackgroundSelf-citationPathophysiology, Evaluation, and Medical Management of Adrenal Disorders
Kutikov, A., Crispen, P. L., & Uzzo, R. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00057-8 · Cited by 31
Berenbaum, S. A., Beltz, A. M., Bryk, K. L. K., & McHale, S. M. (2018) · Archives of Sexual Behavior · doi:10.1007/s10508-017-1112-4 · Cited by 32
“Previous studies of peer preferences in girls with C-CAH suggest that they are more likely than typical girls to prefer boy playmates, 1 Type of CAH reflects the degree of 21-hydroxylase deficiency caused by mutations in CYP21A2 (Merke & Bornstein, 2005).”
BackgroundMinutolo, C., Nadra, A. D., Fernández, C. S., Taboas, M., Buzzalino, N. D., Casali, B., Belli, S., Charreau, E. H., Alba, L. G., & Daín, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015899 · Cited by 33
Mueller, S. C., Merke, D. P., Leschek, E., Fromm, S., VanRyzin, C., & Ernst, M. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001136 · Cited by 31
“Patients with congenital adrenal hyperplasia (CAH), a disorder of both androgen excess and cortisol deficiency (Merke & Bornstein, 2005), exhibit impaired emotional memory, particularly for negative visual stimuli (Maheu et al. 2008) and show perturbed emotional face processing (Mazzone et al. in…”
BackgroundSelf-citationP450 oxidoreductase deficiency and Antley–Bixler syndrome
Arlt, W. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9056-y · Cited by 31
Peffer, M. E., Zhang, J. Y., Umfrey, L., Rudine, A. C., Monaghan, A. P., & DeFranco, D. B. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1042 · Cited by 30
Growth curves for congenital adrenal hyperplasia from a national retrospective cohort
Bretones, P., Riche, B., Pichot, E., David, M., Roy, P., Tardy, V., Kassaï, B., Gaillard, S., Bernoux, D., Morel, Y., et al. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0156 · Cited by 30
A high-androgen microenvironment inhibits granulosa cell proliferation and alters cell identity
McFee, R. M., Romereim, S. M., Snider, A. P., Summers, A. F., Pohlmeier, W. E., Kurz, S. G., Cushman, R. A., Davis, J. S., Wood, J. R., & Cupp, A. S. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111288 · Cited by 30
Human HSD17B1 expression masculinizes transgenic female mice
Saloniemi, T., Welsh, M., Lamminen, T., Saunders, P. T. K., Mäkelä, S., Streng, T., & POUTANEN, M. H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.047 · Cited by 29
Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease?
Bornstein, S. R., Steenblock, C., Chrousos, G. P., Schally, A. V., Beuschlein, F., Kline, G. A., Krone, N. P., Licinio, J., Wong, M., Ullmann, E., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0244-9 · Cited by 29
Self-citationMolecular mechanisms associated with 46,XX disorders of sex development
Knarston, I. M., Ayers, K. L., & Sinclair, A. H. (2016) · Clinical Science · doi:10.1042/cs20150579 · Cited by 29
Choi, J. H., Kim, G.-H., & Yoo, H. (2016) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2016.21.1.1 · Cited by 31
An update to 21-hydroxylase deficient congenital adrenal hyperplasia
Trakakis, E., Basios, G., Trompoukis, P., Labos, G., Grammatikakis, I., & Kassanos, D. P. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903015494 · Cited by 33
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura‐Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0009 · Cited by 35
Collaer, M. L., Brook, C. G. D., Conway, G. S., Hindmarsh, P. C., & Hines, M. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.007 · Cited by 28
“In the most common form of CAH, a deficiency of the enzyme 21-hydroxylase leads to deficient production of cortisol and often of mineralocorticoids (Merke & Bornstein, 2005).”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 28
McNicol, A. M. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2008-132-1263-lotac · Cited by 28
Roberts, E. K., Padmanabhan, V., & Lee, T. M. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.107.067074 · Cited by 28
Mazzone, L., Mueller, S. C., Maheu, F. S., VanRyzin, C., Merke, D. P., & Ernst, M. (2011) · Developmental Neuropsychology · doi:10.1080/87565641.2010.549866 · Cited by 28
“Patients with CAH show hypersecretion of CRH and ACTH, due to lack of glucocorticoid feedback on the hypothalamus-pituitary-adrenal (HPA) axis (Merke & Bornstein, 2005).”
BackgroundSelf-citationMaheu, F. S., Merke, D. P., Schroth, E. A., Keil, M. F., Hardin, J., Poeth, K., Pine, D. S., & Ernst, M. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.11.006 · Cited by 28
“Such overproduction of ACTH stimulates the adrenals and leads to excess adrenal androgen production (Merke and Bornstein, 2005).”
BackgroundMethodSelf-citationMoreira, R. P. P., Villares, S. M., Madureira, G., Mendonca, B. B., & Bachega, T. A. S. S. (2013) · Hormone Research in Paediatrics · doi:10.1159/000353762 · Cited by 29
Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
Balsamo, A., Baronio, F., Ortolano, R., Menabò, S., Baldazzi, L., Natale, V. D., Vissani, S., & Cassio, A. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.593315 · Cited by 27
“The incidence of classic forms (SW and SV) ranges between 1 in 13,000 and 1 in 15,000 live births (42): in most populations, the frequency of heterozygous carriers is 1 in 60.”
BackgroundTen-year evaluation of a Neonatal Screening Program for Congenital Adrenal Hyperplasia
Nascimento, M. L., Cristiano, A. N. B., de Campos, T., Ohira, M., Cechinel, E., Simoni, G., Lee, J. V. D. S., Linhares, R. M. M., & da Silva, P. C. A. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003310 · Cited by 26
Akyürek, N., Atabek, M. E., Eklioğlu, B. S., & Alp, H. (2015) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1658 · Cited by 26
Parental management of adrenal crisis in children with congenital adrenal hyperplasia
Fleming, L., Knafl, K. A., Knafl, G. J., & Riper, M. L. V. (2017) · Journal for Specialists in Pediatric Nursing · doi:10.1111/jspn.12190 · Cited by 27
Treatment of the Enlarged Clitoris
Kaefer, M. A., & Rink, R. C. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00125 · Cited by 26
Schaeffer, T. L., Tryggestad, J. B., Mallappa, A., Hanna, A., Krishnan, S., Chernausek, S. D., Chalmers, L. J., Reiner, W. G., Kropp, B., & Wisniewski, A. B. (2010) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2010-692439 · Cited by 26
Endendijk, J. J., Beltz, A. M., McHale, S. M., Bryk, K., & Berenbaum, S. A. (2016) · Archives of Sexual Behavior · doi:10.1007/s10508-016-0693-7 · Cited by 25
Gender Development in Gender Diverse Children
deMayo, B., Jordan, A. E., & Olson, K. R. (2022) · Annual Review of Developmental Psychology · doi:10.1146/annurev-devpsych-121020-034014 · Cited by 32
Barzon, L., Maffei, P., Sonino, N., Pilon, C., Baldazzi, L., Balsamo, A., Del Maschio, O., Masi, G., Trevisan, M., Pacenti, M., et al. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346358 · Cited by 24
Gomes, L. G., Mendonca, B. B., & Bachega, T. A. S. S. (2020) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000545 · Cited by 27
Congenital Adrenal Hyperplasia Associated with Mutation in an 11β-Hydroxylase-Like Gene in a Cat
Owens, S. L., Downey, M. E., Pressler, B. M., Birkenheuer, A. J., Chandler, D. W., & Scott‐Moncrieff, J. C. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2012.00971.x · Cited by 22
Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
Tsuji‐Hosokawa, A., & Kashimada, K. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7030036 · Cited by 31
Ueland, G. Å., Dahl, S. R., Methlie, P., Hessen, S., Husebye, E. S., & Thorsby, P. M. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.05.012 · Cited by 23
Congenital Adrenal Hyperplasia: Issues in Diagnosis and Treatment in Children
Sharma, R., & Seth, A. (2013) · The Indian Journal of Pediatrics · doi:10.1007/s12098-013-1280-8 · Cited by 27
A Diagnostic Approach to Adrenal Cortical Lesions
McNicol, A. M. (2008) · Endocrine Pathology · doi:10.1007/s12022-008-9055-x · Cited by 24
Substitution therapy in adult patients with congenital adrenal hyperplasia
Reisch, N. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.11.002 · Cited by 23
Rossi, C., Calton, L. J., Brown, H. A., Gillingwater, S., Wallace, A. M., Petrucci, F., Ciavardelli, D., Urbani, A., Sacchetta, P., & Morris, M. R. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.109 · Cited by 24
Congenital adrenal hyperplasia
Demirci, C., & Witchel, S. F. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00216.x · Cited by 22
Skordis, N., Shammas, C., Efstathiou, E., Kaffe, K., Neocleous, V., & Phylactou, L. A. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.05.013 · Cited by 23
Neonatal mass screening for 21-hydroxylase deficiency
Tajima, T., & Fukushi, M. (2016) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.25.1 · Cited by 22
Chaudhari, M., Johnson, E. K., Dajusta, D. G., & Nahata, L. (2017) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2017.11.011 · Cited by 22
Update: Newborn Screening for Endocrinopathies
Pass, K. A., & Neto, E. C. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.08.005 · Cited by 22
Adrenal Insufficiency in Children With Nephrotic Syndrome on Corticosteroid Treatment
Bakar, K. A., Khalil, K., Lim, Y. N., Yap, Y. C., Appadurai, M., Sidhu, S., Lai, C. S., Zaini, A. A., Samingan, N. B., & Jalaludin, M. Y. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00164 · Cited by 21
Russian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 28
Kung, K. T. F., Louie, K., Spencer, D., & Hines, M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105616 · Cited by 23
Nygren, U., Nyström, H. F., Falhammar, H., Hagenfeldt, K., Nordenskjöld, A., & Södersten, M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12226 · Cited by 21
Brown, E. C. Z., Steadman, C. J., Lee, T. M., Padmanabhan, V., Lehman, M. N., & Coolen, L. M. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12871 · Cited by 21
“…been documented in several species including rat (Wolf et al., 2002; Wu et al., 2010), rhesus macaque (Goy et al., 1988; Abbott et al., 2005), human (Merke & Bornstein, 2005) and sheep (Wood & Foster, 1998; Robinson et al., 2002; Padmanabhan et al., 2006; Bormann et al., 2011; Hogg et al., 2011).”
BackgroundBachelot, A., Chakhtoura, Z., Samara‐Boustani, D., Dulon, J., Touraine, P. A., & Polak, M. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/326275 · Cited by 23
Metadata
- Authors
- Merke, D. P., & Bornstein, S. R.
- Affiliations
- National Institutes of Health (US)
- Technische Universität Dresden (DE)
- Corresponding author
- Merke, Deborah P
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 365
- Issue
- 9477
- Pages
- 2125-2136
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2913693499
- Cited by
- 628
- References
- 153
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 22 · 2023: 28 · 2022: 33 · 2021: 34 · 2020: 27 · 2019: 21 · 2018: 29 · 2017: 37 · 2016: 42 · 2015: 36 · 2014: 38 · 2013: 33 · 2012: 43
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, cortisol deficiency, aldosterone deficiency, hyperandrogenism, newborn screening, prenatal diagnosis, hormone replacement therapy, iatrogenic Cushing's syndrome, infertility, metabolic syndrome, pathophysiology, diagnosis
- MeSH terms
- Adrenal Hyperplasia, Congenital, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review